Recent Trends in Electrospun Nanofibers for Drug Delivery Systems in Asia
Indonesian Journal of Pharmacy · 04.05.2026 · 257-286
DOI: 10.22146/ijp.29212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 04.05.2026. Verfasst von Nurvidian Khasanah und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).
Abstract (Originalsprache)
Electrospun nanofibers have gained increasing attention as an advanced platform for drug delivery due to their high surface-area-to-volume ratio, tunable porosity, and ability to incorporate a wide range of therapeutic agents. These structural properties enable precise control over drug loading and release kinetics, making electrospun nanofibers a promising alternative to conventional delivery systems such as liposomes, hydrogels, micelles, and polymeric nanoparticles. This review provides a comprehensive overview of electrospinning fundamentals, polymer–solvent interactions, and key processing parameters influencing nanofiber morphology and performance. Various drug encapsulation strategies, including blend, coaxial, and emulsion electrospinning, are discussed together with their advantages and limitations in achieving controlled and stimuli-responsive drug release. A narrative literature search covering the period 2015–2025 identified 214 studies, of which 137 met the eligibility criteria and were included in this review. The findings reveal significant research progress across several Asian countries, particularly China, Japan, South Korea, India, and Malaysia, where electrospun nanofibers are actively explored for applications in cancer therapy, wound healing, topical drug delivery, and tissue engineering. The integration of natural bioactive compounds, implantable nanofiber systems, and stimuli-responsive architectures further highlights the rapid innovation occurring in this region. Despite these advancements, several challenges remain, including high production costs, limitations in large-scale manufacturing, solvent toxicity, environmental concerns, and the lack of standardized regulatory frameworks. Addressing these issues through improved fabrication technologies, modular electrospinning systems, solvent recycling strategies, and harmonized quality standards will be essential for successful commercial translation. Overall, electrospun nanofibers represent a rapidly evolving and highly adaptable platform with strong potential to advance future drug delivery strategies, particularly within Asia’s growing pharmaceutical and biomedical landscape.
Zitieren
APA
Khasanah, N., Sutriyo, S., Fatimah, F., Noordam, E. R., Hardiyati, I., Setianingsih, L. E., Hidayat, A. W., Aswan, P. A., Palmado, I. A., Adiwisastra, N. G., & Dewi, M. S. (2026). Recent Trends in Electrospun Nanofibers for Drug Delivery Systems in Asia. Indonesian Journal of Pharmacy, 257-286. https://doi.org/10.22146/ijp.29212
Vancouver
Khasanah N, Sutriyo S, Fatimah F, Noordam ER, Hardiyati I, Setianingsih LE, et al. Recent Trends in Electrospun Nanofibers for Drug Delivery Systems in Asia. Indonesian Journal of Pharmacy. 2026:257-286. doi:10.22146/ijp.29212
BibTeX
@article{Khasanah2026,
author = {Khasanah, Nurvidian and Sutriyo, Sutriyo and Fatimah, Fatimah and Noordam, Errol Rakhmad and Hardiyati, Iin and Setianingsih, Lyliana Endang and Hidayat, Afif Wahyudi and Aswan, Pedro Anugerah and Palmado, Ignasius Agyo and Adiwisastra, Nuzul Gyanata and Dewi, Masita Sari},
title = {Recent Trends in Electrospun Nanofibers for Drug Delivery Systems in Asia},
journal = {Indonesian Journal of Pharmacy},
year = {2026},
pages = {257--286},
doi = {10.22146/ijp.29212}
}
EUVIMED